Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A I Veldkamp

Showing results (11-20 of 13) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 13 results.
British Journal of Pharmacology|July 2, 2010
Influence of 5-aminosalicylic acid on 6-thioguanosine phosphate metabolite levels: a prospective study in patients under steady thiopurine therapyP de Graaf, N K H de Boer, D R Wong, et al.
The Journal of Infectious Diseases|June 9, 2001
The steady-state pharmacokinetics of efavirenz and nevirapine when used in combination in human immunodeficiency virus type 1-infected personsA I Veldkamp, M Harris, J S Montaner, et al.
AIDS (London, England)|June 15, 2000
The steady-state pharmacokinetics of nevirapine during once daily and twice daily dosing in HIV-1-infected individualsR P van Heeswijk, A I Veldkamp, J W Mulder, et al.
Pageof 2

Showing results (11-20 of 13) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 13 results.
British Journal of Pharmacology|July 2, 2010
Influence of 5-aminosalicylic acid on 6-thioguanosine phosphate metabolite levels: a prospective study in patients under steady thiopurine therapyP de Graaf, N K H de Boer, D R Wong, et al.
The Journal of Infectious Diseases|June 9, 2001
The steady-state pharmacokinetics of efavirenz and nevirapine when used in combination in human immunodeficiency virus type 1-infected personsA I Veldkamp, M Harris, J S Montaner, et al.
AIDS (London, England)|June 15, 2000
The steady-state pharmacokinetics of nevirapine during once daily and twice daily dosing in HIV-1-infected individualsR P van Heeswijk, A I Veldkamp, J W Mulder, et al.
Pageof 2